Acceleration of age-induced proteolysis in the guinea pig lens nucleus by in vivo exposure to hyperbaric oxygen: A mass spectrometry analysis.
Aging
/ physiology
Animals
Aquaporins
/ metabolism
Cataract
/ etiology
Chromatography, Liquid
Crystallins
/ metabolism
Cytoskeletal Proteins
/ metabolism
Disease Models, Animal
Eye Proteins
/ metabolism
Guinea Pigs
Hyperbaric Oxygenation
/ adverse effects
Lens Nucleus, Crystalline
/ metabolism
Proteolysis
/ drug effects
Tandem Mass Spectrometry
alpha-Crystallin A Chain
/ metabolism
Alpha crystallin
Aquaporin-0
Hyperbaric oxygen
Lens
Mass spectrometry
Nuclear cataract
Protein truncation
αA66-80 peptide
Journal
Experimental eye research
ISSN: 1096-0007
Titre abrégé: Exp Eye Res
Pays: England
ID NLM: 0370707
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
received:
31
03
2021
revised:
21
06
2021
accepted:
30
06
2021
pubmed:
8
7
2021
medline:
9
10
2021
entrez:
7
7
2021
Statut:
ppublish
Résumé
Hyperbaric oxygen (HBO) treatment of animals or ocular lenses in culture recapitulates many molecular changes observed in human age-related nuclear cataract. The guinea pig HBO model has been one of the best examples of such treatment leading to dose-dependent development of lens nuclear opacities. In this study, complimentary mass spectrometry methods were employed to examine protein truncation after HBO treatment of aged guinea pigs. Quantitative liquid chromatography-mass spectrometry (LC-MS) analysis of the membrane fraction of guinea pig lenses showed statistically significant increases in aquaporin-0 (AQP0) C-terminal truncation, consistent with previous reports of accelerated loss of membrane and cytoskeletal proteins. In addition, imaging mass spectrometry (IMS) analysis spatially mapped the acceleration of age-related αA-crystallin truncation in the lens nucleus. The truncation sites in αA-crystallin closely match those observed in human lenses with age. Taken together, our results suggest that HBO accelerates the normal lens aging process and leads to nuclear cataract.
Identifiants
pubmed: 34233175
pii: S0014-4835(21)00263-3
doi: 10.1016/j.exer.2021.108697
pmc: PMC8429224
mid: NIHMS1723366
pii:
doi:
Substances chimiques
Aquaporins
0
Crystallins
0
Cytoskeletal Proteins
0
Eye Proteins
0
alpha-Crystallin A Chain
0
aquaporin 0
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
108697Subventions
Organisme : NEI NIH HHS
ID : R01 EY024258
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY013462
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY008126
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY002027
Pays : United States
Organisme : NEI NIH HHS
ID : U54 EY032442
Pays : United States
Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.
Références
J Biol Chem. 1988 Dec 15;263(35):19020-3
pubmed: 3198609
J Proteome Res. 2010 Apr 5;9(4):1716-26
pubmed: 20131910
J Proteome Res. 2009 Jul;8(7):3278-83
pubmed: 19326924
Mol Vis. 2013;19:267-80
pubmed: 23401655
J Proteome Res. 2006 Oct;5(10):2554-66
pubmed: 17022627
Photochem Photobiol. 1985 Aug;42(2):125-8
pubmed: 2996041
Exp Eye Res. 1975 Mar;20(3):223-30
pubmed: 1122997
Exp Eye Res. 2004 May;78(5):925-31
pubmed: 15051474
Curr Eye Res. 1995 Sep;14(9):837-41
pubmed: 8529423
Bioinformatics. 2010 Apr 1;26(7):966-8
pubmed: 20147306
Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4641-51
pubmed: 16303961
Exp Eye Res. 1999 Apr;68(4):493-504
pubmed: 10192807
Curr Eye Res. 1998 Nov;17(11):1037-43
pubmed: 9846621
J Ocul Pharmacol Ther. 2000 Apr;16(2):121-35
pubmed: 10803423
Aging Cell. 2016 Apr;15(2):237-44
pubmed: 26751411
Anal Bioanal Chem. 2015 Mar;407(8):2311-20
pubmed: 25665708
Invest Ophthalmol Vis Sci. 2010 Jun;51(6):3107-14
pubmed: 20053973
Biochim Biophys Acta Proteins Proteom. 2019 Sep;1867(9):831-839
pubmed: 31226490
Exp Eye Res. 2005 May;80(5):709-25
pubmed: 15862178
J Proteome Res. 2009 Aug;8(8):3872-81
pubmed: 19522537
Photochem Photobiol. 1995 Jul;62(1):87-93
pubmed: 7638274
Exp Eye Res. 2007 Mar;84(3):493-9
pubmed: 17196965
Mol Vis. 2004 Mar 26;10:215-22
pubmed: 15064681
Prog Biophys Mol Biol. 2014 Jul;115(1):21-31
pubmed: 24613629
Exp Eye Res. 2001 Nov;73(5):625-37
pubmed: 11747363
Age (Dordr). 2011 Jun;33(2):131-41
pubmed: 20686926
Invest Ophthalmol Vis Sci. 2000 May;41(6):1460-6
pubmed: 10798663
Invest Ophthalmol Vis Sci. 2000 Sep;41(10):3061-73
pubmed: 10967065
Invest Ophthalmol Vis Sci. 2006 Jul;47(7):2990-6
pubmed: 16799044
Exp Eye Res. 2015 Mar;132:151-60
pubmed: 25639202
Exp Eye Res. 1995 Mar;60(3):219-35
pubmed: 7789403
Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7398-405
pubmed: 26574799
Anal Chem. 1997 Dec 1;69(23):4751-60
pubmed: 9406525
Biochemistry. 2004 Aug 3;43(30):9856-65
pubmed: 15274640
J Biol Chem. 2008 Mar 28;283(13):8477-85
pubmed: 18227073
Aging Cell. 2012 Dec;11(6):1125-7
pubmed: 22805275
Br J Ophthalmol. 1984 Feb;68(2):113-7
pubmed: 6691953
PLoS One. 2011 Apr 28;6(4):e19291
pubmed: 21552534
Exp Eye Res. 2012 Aug;101:72-81
pubmed: 22728317
Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4319-29
pubmed: 19387068
Invest Ophthalmol Vis Sci. 1999 Mar;40(3):657-67
pubmed: 10067969
Prog Retin Eye Res. 2010 Nov;29(6):487-99
pubmed: 20472092
Anal Chem. 2013 Jul 16;85(14):6767-74
pubmed: 23718750
Photochem Photobiol. 2008 Nov-Dec;84(6):1589-95
pubmed: 18627516